RSS   Newsletter   Contact   Advertise with us

Prime Therapeutics selects Kenneth H. Paulus as president and CEO

Christian Fernsby | Eagan, Minn., USA | April 12, 2019
Kenneth H. PaulusPrime Therapeutics, a clinical-stage biotechnology company, announced that it has selected Kenneth H. Paulus as president and CEO, effective May 7, 2019.
Mr. Paulus comes to Prime with more than 30 years of leadership in the health care sector.

Currently, Mr. Paulus is an executive advisor with Water Street Healthcare Partners.

From 2005 to 2015, Mr. Paulus held leadership roles at Allina Health; including CEO, president and chief operating officer.

Earlier in his career, he served as president and CEO of Harvard Vanguard Medical Associates, the staff model partner of Harvard Pilgrim Healthcare in Boston.

While at Harvard Vanguard, Mr. Paulus led creation of Atrius Health and served as the system's first president and CEO.

Prior to Atrius, he was COO of Partners Community Healthcare, the risk-bearing entity of Partners Healthcare System.

Mr. Paulus earned a degree in biological sciences from Augustana College in Rock Island, Ill., and a Master's in Health Care Administration from the University of Minnesota.